Tom Davis

Collierville, TN (USA)
Role(s):
C-Level Executive (CEO, CFO, etc.)

arGentis Pharmaceuticals

Location: Collierville
Industry: Pharmaceuticals
Year Founded: 2007
Number Employees: 1-10 people
Business Stage: Growth (not profitable)
Entity Type: Limited Liability Company
Description: arGentis™ Pharmaceuticals, LLC is a private TN based pharmaceutical company with a mid-stage Orphan Drug treatment (ARG201) for late stage diffuse systemic scleroderma (dcSSc). The company is seeking capital to complete a Pivotal Clinical Trial, which will enable obtaining marketing approval for ARG201. The Company has a genotype marker (ROT1) that predicts patient response to treatment by oral tolerance for treatments like ARG201 for dcSSc. Furthermore, arGentis™ has a treatment for Rheumatoid arthritis (ARG301) that is in a Phase I Clinical Trial in the US.